Non-clinical safety comparability study for the commercial manufacturing site change of Reassortant Rotavirus Vaccine, Live, Oral, Hexavalent (Vero Cell)

doi:10.3760/cma.j.cn311962-20250331-00019

International Journal of Biologicals ›› 2026, Vol. 49 ›› Issue (1) : 13-20.

PDF(17306 KB)

International Journal of Biologicals ›› 2026, Vol. 49 ›› Issue (1) : 13-20. DOI: 10.3760/cma.j.cn311962-20250331-00019

Non-clinical safety comparability study for the commercial manufacturing site change of Reassortant Rotavirus Vaccine, Live, Oral, Hexavalent (Vero Cell)

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 49(1): 13-20 https://doi.org/10.3760/cma.j.cn311962-20250331-00019

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(17306 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export